LTRN logo
LTRN NASDAQ US

Lantern Pharma Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jun 2020
$1.62
▲ +$0.20 (+14.08%)
Vol 1.3M
3
Quality Score
fail
Mkt Cap
$33.9M
ROE
-126.0%
D/E
0.00
Beta
1.52
52W
$3–$6

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

JSPR
Jasper Therapeutics Inc
$51.2M
ALLR
Allarity Therapeutics Inc
$17.3M
OTLK
Outlook Therapeutics Inc
$101.3M
TVGN
Tevogen Bio Holdings Inc
$65.8M
KTTA
Pasithea Therapeutics Corp
$29.8M
BIAF
bioAffinity Technologies Inc
$5.3M
MDCX
Medicus Pharma Ltd
$38.4M
CUE
Cue Biopharma Inc
$27.9M

Earnings

Beat rate: 80.0%
Next Report May 13, 2026
Quarter EPS Est EPS Act Surprise
Mar 2026 — — —
Dec 2025 $-0.47 $-0.36 +$0.11
Sep 2025 $-0.48 $-0.39 +$0.09
Jun 2025 $-0.49 $-0.40 +$0.09

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -99.9% -83.3% -99.9% -99.9% -99.9% -126.0%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 3.52 4.86 3.52 3.52 3.52 3.33

Key Ratios

ROA (TTM)
-97.4%
P/B
1.6
EPS (TTM)
$-1.75
CF/Share
$-1.39
52W High
$6.12
52W Low
$2.55
$2.55 52-Week Range $6.12

How does LTRN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

LTRN AAPG ABEO ABOS ABP

LTRN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.6
▼ 34% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

LTRN profitability vs Biotechnology peers

ROE
-126.0%
▼ 87% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-97.4%
▼ 108% below peers (-46.7%)
vs Peers
vs Industry
Weak

LTRN financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.3
▼ 25% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.5
▲ 57% above peers (1.0)
vs Peers
vs Industry
More volatile

LTRN fundamentals radar

LTRN Peer median Industry

LTRN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

LTRN vs peers: key metrics

Latest News

Lantern Pharma Stock Falls 10% After FDA Clears Investigational New Drug Application …
Nasdaq · Mar 27